← Leaderboards
Ken Nakamura
University Of Chicago
$8,216,382
Attributed
$10,360,196
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2009–24$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,360,196 · 6
By mechanism
R01$5,810,617 · 2
RF1$3,597,332 · 1
K08$877,986 · 1
F30$41,680 · 1
P20$32,581 · 1
Top collaborators
- Myriam Marianne Chaumeil1 shared
- Todd C Mcdevitt1 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Kevin Murphy$19,998
- Michael Fisch$22,913
- Rebecca K Journey$12,487
- Suriyanarayanan Vaikuntanathan$499,888
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaNeuronsCellsBaseLeadGlycolysisFunctional DisorderInnovationProductionNeurodegenerative DisordersInsightBioenergeticsConsumptionFailureCessation Of LifeCell PhysiologyGeneticRespiratory PhysiologySynapsesMitochondrial DysfunctionPlayParkinson DiseaseDopaminergic NeuronPathogenesis
Grant awards (20)
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$620,722
R01 · FY2024 · AG · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$645,796
R01 · FY2023 · AG · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$645,796
R01 · FY2022 · AG · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$460,375
R01 · FY2022 · AG · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$645,796
R01 · FY2021 · AG · contact PI
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells$690,296
R01 · FY2020 · AG · contact PI
Understand and probing disrupted glucose metabolism in Alzheimer's disease$3,597,332
RF1 · FY2019 · AG · contact PI
Determining how neural activity impairs bioenergetics in PD pathogenesis$416,390
R01 · FY2019 · NS · contact PI
Determining how neural activity impairs bioenergetics in PD pathogenesis$417,386
R01 · FY2018 · NS · contact PI
Determining how neural activity impairs bioenergetics in PD pathogenesis$422,700
R01 · FY2017 · NS · contact PI
Determining how neural activity impairs bioenergetics in PD pathogenesis$422,700
R01 · FY2016 · NS · contact PI
Determining how neural activity impairs bioenergetics in PD pathogenesis$422,660
R01 · FY2015 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$190,458
K08 · FY2013 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$190,458
K08 · FY2012 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$166,914
K08 · FY2011 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$113,839
K08 · FY2010 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$51,239
K08 · FY2010 · NS · contact PI
Regulation of mitochondrial morphology by alpha-synuclein$165,078
K08 · FY2009 · NS · contact PI
GLUTATHIONE AND DOPAMINERGIC NEURONAL SURVIVAL$41,680
F30 · FY2000 · MH
FEASIBILITY OF STUDYING THE PHYSIOLOGY AND PHARMACOLOGY OF HUMAN FETAL AIRWAY$32,581
P20 · FY2000 · RR